 Deloitte Consulting LLP recently released Linking Improvement to Transformation: A Global Manufacturing Strategy for Life Sciences. The main conclusion of this point of view is that manufacturing operations are a great untapped source of value within life sciences companies. Well-integrated, flexible and cost-efficient manufacturing networks can help companies balance short- and long-term challenges and create value for patients and shareholders. This paper explores current life sciences industry challenges and presents an effective approach to developing responsive and cost-effective global manufacturing strategies that drive growth and value. We explore Deloitte’s approach to global manufacturing strategy development and how we help our clients focus on patient and shareholder value. We have developed the Strategic Manufacturing Index (SMI) tool set that provides a standardized approach to calculate and compare demand, capacity and utilization across a company’s entire manufacturing network. The result of using SMI is that manufacturing leaders can obtain a standardized and holistic view of demand, capacity and utilization both within and across a global network of sites. This insight will allow them to make better long-term strategic decisions to align evolving product portfolio requirements with the capacities and capabilities of the global manufacturing network. Also included in this attachment is a case study that details how Deloitte Consulting assisted a large global pharmaceutical company in constructing a long-term strategy that helped the client achieve numerous benefits. Related Content:
Overview: Life Sciences |
